CYFRA 21—1 - clinical applications and analytical requirements

References

• Silverberg E. Cancer statistics. Cancer Abstracts 1987; 37: 2–19
   Google Scholar
• Rubin P. Clinical Oncology: A Multidisciplinary Approach for Physicians and Students7th ed. W.B. Saunders Company, Philadelphia 1993
   Google Scholar
• Maasen W, Greschuchna D, Kaiser D, Liebig S, Loddenkemper R, Stapenhorst K, Toomes H. Recommendations on diagnosis staging, and surgical therapy of lung cancer. Thorac Cardiovasc Surg 1988; 36: 295–306
   PubMedGoogle Scholar
• Drings P. Die Chemotherapie des Bronchialkarzinoms.In: Thoraxtumouren (P. Drings, I. Vogt-Moykopf, eds.). Springer, Berlin, Heidelberg, New York, London, Paris, 1991; 1991; 1: 219–230
   Google Scholar
• Bodenmüller H, Banauch D, Ofenloch B, Jaworek D, Dessauer A. Technical evaluation of a new automated tumour marker assay: The enzymun-test CYFRA 21—1. Tumour Associated Antigens, Oncogenes, Receptors, Cytokines in Tumour Diagnosis and Therapy at the Beginning of the Nineties. Cancer of the Breast - State and Trends in Diagnosis and Therapy, R. W. Klapdor. Zuckschwerdt Verlag, Miinchen, Bern, Wien 1992; 137–138
   Google Scholar
• Stieber P, Hasholzner U, Bodenmuller H, Nagel D, Sunder-Plassmann L., Dienemann H, Meier W, Fateh-Moghadam A. CYFRA 21—1 A new Marker in Lung Cancer. Cancer 1993; 7: 707–713
   Google Scholar
• Pujol J-L, Grenier J, Daures J-P, Daver A, Pujol H, Michel F-B. Serum Fragment of Cytokeratin Subunit 19 Measured by CYFRA 21—1. Immunoradiometric Assay as a Marker of Lung Cancer. Cancer Research 1993; 53: 61–66
   PubMed Web of Science ®Google Scholar
• Ebert W, Leichtweis B, Schapohler B, Muley T. The New Tumour Marker CYFRA 21—1 is Superior to SCC Antigen and CEA in the primary Diagnosis of Lung Cancer. Tumour Diagn Ther 1993; 3: 91–99
   Google Scholar
• Ebert W, Dienemann H, Fateh-Moghadam A, Scheulen M, Konietzko N, Schleich T, Bombardieri E. Cytokeratin 19 Fragment CYFRA 21—1 Compared with Carcinoembryonic Antigen, Squamous Cell Carcinoma Antigen and Neuron-Specific Enolase in Lung Cancer. Results of an International Multicentre Study, Eur J Clin Chem Clin Biochem 1994; 32: 189–199
   PubMedGoogle Scholar
• Rastel D, Ramaioli A., Cornillie F, Thirion B. CYFRA 21—1, a Sensitive and Specific New Tumour Marker for Squamous Cell Lung Cancer. Report of the First European Multicenter Evaluation. Eur J Cancer 1994; 30A: 601–606
   PubMed Web of Science ®Google Scholar
• van der Gaast A., Schoenmakers CHH, Kok T C, Blijenberg B G, Comillie F., Splinter TAW. Evaluation of a new tumour marker in patients with non-small-cell lung cancer: CYFRA 21—1. Br J Cancer 1994; 69: 525–528
   PubMed Web of Science ®Google Scholar
• Fontana R S, Sanderson D R, Woolner L.B, Taylor W F, Miller W E, Muhm J R. Lung Cancer Screening: The Mayo program. J Occup Med. 1986; 28: 146–750
   Google Scholar
• Levin M L, Tockman M S, Frost J K, Ball WC, Jr. Lung Cancer mortality in males screened by chest X-ray and cytologic sputum examination: A preliminary report. Early Detection and Localization of Lung Tumours in High Risk Groups, P R. Band. Springer-Verlag, Berlin and New York 1982; 138–146
   Google Scholar
• World Health Organization. Histological Classification of Lung Tumours. WHO, Geneva 1981
   Google Scholar
• Hermanek P, Sobin L. TNM Classification of Malignant Tumours. International Union against Cancer (UICC). Springer, Berlin 1987; 4
   Google Scholar
• Ebert W, Dienemann H, Fateh-Moghadam A, Scheulen M, Konietzko N, Schleich T, Bombardieri E, Banauch D, Mülhofer W. Enzymun-Test CYFRA 21—1:Results of the clinical phase 1 multicenter study in bronchogenic carcinoma. Current Tumour Diagnosis: Applications, Clinical Relevance, Research, Trends Cancer of the Lung - State and Trends in Diagnosis and Therapy, R.W. Klapdor. Zuckschwerdt Verlag, Miinchen, Bern, Wien, New York, in press
   Google Scholar
• Dienemann H, Stieber P. Lung cancer and clinical usefulness of CYFRA. 21–1, This issue
   Google Scholar
• Bodenmüller H. The biochemistry of CYFRA 21—1 and other cytokeratin tests, This issue
   Google Scholar
• Oremek G M, Siekemeier R, Seiffert U B, Zirker M, Kirsten R. Die Bedeutung van CYFRA 21—1 in der pneumologischen Differentialdiagnostik Vergleichende Untersuchung mittels EIA und RIA. Lab med 1994; 18: 100–104
   Google Scholar